Header cover image

South Korean (KOSPI) Life Sciences Industry Analysis

UpdatedApr 26, 2024
DataAggregated Company Financials
Companies34
  • 7D-0.5%
  • 3M2.8%
  • 1Y2.2%
  • YTD-0.7%

In the last week, the Life Sciences industry is up 3.1%, with LigaChem Biosciences up 9.8%. Overall in the last year, the industry is flat. Earnings are forecast to grow by 17% annually.

Industry Valuation and Performance

Has the South Korean Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 26 Apr 2024₩62.8t₩4.7t₩654.7b20x95.9x13.5x
Sun, 24 Mar 2024₩66.7t₩4.6t₩656.5b19.8x101.6x14.4x
Tue, 20 Feb 2024₩64.2t₩4.5t₩714.4b34.1x89.8x14.2x
Thu, 18 Jan 2024₩59.6t₩4.5t₩714.4b33.3x83.4x13.2x
Sat, 16 Dec 2023₩55.7t₩4.5t₩721.5b30.5x77.1x12.3x
Mon, 13 Nov 2023₩57.0t₩4.4t₩660.9b21.7x86.2x13x
Wed, 11 Oct 2023₩57.4t₩4.4t₩660.9b34.8x86.8x13.1x
Fri, 08 Sep 2023₩57.6t₩4.4t₩660.0b25.5x87.3x13.1x
Sun, 06 Aug 2023₩62.0t₩4.2t₩673.4b28.9x92.1x14.8x
Tue, 04 Jul 2023₩58.1t₩4.2t₩673.4b30.3x86.3x13.9x
Thu, 01 Jun 2023₩61.4t₩4.3t₩615.2b32.7x99.7x14.3x
Sat, 29 Apr 2023₩60.9t₩4.1t₩626.3b27.1x97.3x14.9x
Mon, 27 Mar 2023₩61.8t₩4.0t₩711.1b26x86.9x15.3x
Wed, 22 Feb 2023₩62.6t₩3.5t₩427.8b21.5x146.2x18x
Fri, 20 Jan 2023₩62.4t₩3.5t₩426.6b20.2x146.4x17.9x
Sun, 18 Dec 2022₩65.2t₩3.4t₩428.7b24.3x152x19x
Tue, 15 Nov 2022₩69.7t₩3.0t₩448.5b24.4x155.3x23.3x
Thu, 13 Oct 2022₩63.5t₩3.0t₩448.5b22x141.7x21.3x
Sat, 10 Sep 2022₩63.9t₩3.0t₩448.7b28.5x142.4x21.4x
Mon, 08 Aug 2022₩71.1t₩2.7t₩454.7b28.8x156.3x26.2x
Wed, 06 Jul 2022₩63.7t₩2.7t₩454.7b29.2x140x23.4x
Fri, 03 Jun 2022₩67.3t₩2.7t₩456.1b27x147.6x24.9x
Sun, 01 May 2022₩66.4t₩2.4t₩379.4b23x174.9x27.4x
Tue, 29 Mar 2022₩61.3t₩2.4t₩390.9b23.9x156.8x25.4x
Thu, 24 Feb 2022₩57.4t₩2.4t₩409.6b26x140x24.4x
Sat, 22 Jan 2022₩61.3t₩2.3t₩412.7b25.7x148.6x26.1x
Mon, 20 Dec 2021₩71.2t₩2.3t₩412.7b29.1x172.4x30.3x
Wed, 17 Nov 2021₩64.2t₩2.1t₩329.9b25.1x194.5x29.9x
Fri, 15 Oct 2021₩64.0t₩2.1t₩329.9b26.6x193.9x29.8x
Sun, 12 Sep 2021₩69.4t₩2.2t₩330.9b35.9x209.8x31.4x
Tue, 10 Aug 2021₩71.2t₩2.2t₩336.8b37.8x211.3x32.2x
Mon, 03 May 2021₩62.1t₩2.1t₩247.5b38.5x250.8x29.8x
Price to Earnings Ratio

250.8x


Total Market Cap: ₩62.1tTotal Earnings: ₩247.5bTotal Revenue: ₩2.1tTotal Market Cap vs Earnings and Revenue0%0%0%
South Korean Life Sciences Industry Price to Earnings3Y Average 139.6x202220232024
Current Industry PE
  • Investors are pessimistic on the South Korean Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 97.3x which is lower than its 3-year average PE of 140x.
  • The 3-year average PS ratio of 21.0x is higher than the industry's current PS ratio of 13.7x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have grown 38% per year over the last three years.
  • Revenues for these companies have grown 31% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the South Korean Healthcare industry?

KR Market-0.36%
Healthcare0.63%
Life Sciences-0.51%
Clinical Research and Equipment-0.51%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
A141080 LigaChem Biosciences₩66.20k6.6%
+₩641.9b
71.9%PS69.7x
A445680 Curiox Biosystems₩58.80k20.7%
+₩81.0b
n/aPS69.5x
A220100 FutureChemLtd₩12.84k31.4%
+₩67.8b
71.7%PS20.3x
A237690 ST PharmLtd₩86.40k3.7%
+₩58.7b
9.9%PE83.5x
A359090 C&R Research₩2.03k22.3%
+₩20.3b
55.1%PE20.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

A278650

₩3,860.00

HLB bioStepLtd

7D

0.3%

1Y

-7.9%

A359090

₩2,030.00

C&R Research

7D

22.3%

1Y

55.1%

A445680

₩58,800.00

Curiox Biosystems

7D

20.7%

1Y

n/a

A141080

₩66,200.00

LigaChem Biosciences

7D

6.6%

1Y

71.9%

A223250

₩2,945.00

DreamCIS

7D

8.1%

1Y

5.7%

A220100

₩12,840.00

FutureChemLtd

7D

31.4%

1Y

71.7%

A383930

₩6,110.00

DT&CRO

7D

-5.0%

1Y

15.7%

A246250

₩4,705.00

SLS BIO

7D

-5.3%

1Y

-41.1%

A086040

₩5,440.00

Biotoxtech

7D

-0.9%

1Y

-40.0%

A002630

₩532.00

ORIENT BIO

7D

-2.0%

1Y

-13.2%